US OptionsDetailed Quotes

TTOO250117P500

Watchlist

0.40
0.000.00%

15min DelayClose Oct 13 16:00 ET

0.00High0.00Low

T2 Biosystems Stock Discussion

Trytosaveabit

Dec 9 08:07

Update

$T2 Biosystems (TTOO.US)$ T2 Biosystems Announces Plans to License Its Proprietary Technology to Expand Its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
GlobeNewswire· 6 mins ago
Intends to accelerate broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue stream
LEXINGTON, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the "Company"), a leader in the rapid detection o...

Jaguar8

Nov 14 19:54

Why on watchlist? Good ER. Low float

$T2 Biosystems (TTOO.US)$

Jaguar8

Nov 14 15:08

NEWS ER

$T2 Biosystems (TTOO.US)$
T2 Biosystems (NASDAQ:TTOO) reported Q3 2024 financial results with total revenue of $2.0 million, up 34% year-over-year.
Sepsis test panel revenue reached $1.4 million, also increasing 34%.
The company secured 11 T2Dx® Instrument contracts and initiated an exclusive U.S. distribution agreement with Cardinal Health.
Net loss was $10.1 million ($0.57 per share), improving from $15.4 million loss in Q3 2023.
Cash position stood at $2.1 million as of September 30...

Ultratech

Nov 9 22:01

$T2 Biosystems (TTOO.US)$
let's go sit at the bottom again

Teo knows

Oct 23 10:39

$T2 Biosystems (TTOO.US)$ bravo

Trytosaveabit

Oct 8 08:11

Update

$T2 Biosystems (TTOO.US)$ T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform

Jaguar8

Oct 8 08:02

NEWS

$T2 Biosystems (TTOO.US)$
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform

Stock_Drift

Oct 7 09:12

T2 Biosystems.

$T2 Biosystems (TTOO.US)$

Trytosaveabit

Oct 7 08:12

Update

$T2 Biosystems (TTOO.US)$ Reuters· 6 mins ago
T2 Biosystems Announces Exclusive U.S. Agreement With Cardinal Health to Sell Its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens

Jaguar8

Oct 7 08:05

NEWS

$T2 Biosystems (TTOO.US)$
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
T2 Biosystems (NASDAQ: TTOO) has entered into a multi-year exclusive U.S. agreement with Cardinal Health (NYSE: CAH) for the distribution of its FDA-cleared direct-from-blood diagnostics for rapid sepsis detection. The agreement covers the T2Dx® Instrument, T2Bacteria® Panel, and T2Candida® Panel. ...

No comment yet